Patterns of anthracycline retention modulation in human tumor cells

Area of Science:

• Oncology
• Pharmacology
• Cell Biology

Background:

• Anthracyclines like doxorubicin and daunomycin are vital chemotherapy agents.
• Tumor cells can develop resistance to these drugs through various mechanisms, including altered drug efflux.
• Efflux blockers (e.g., phenothiazines, verapamil) are investigated to overcome drug resistance.

Purpose of the Study:

• To investigate the heterogeneity of cellular anthracycline content and sensitivity to efflux modulators in human tumor cells.
• To examine changes in drug retention and modulator sensitivity in serial tumor samples from patients undergoing treatment.

Main Methods:

• Laser excitation was used to quantify intracellular doxorubicin and daunomycin levels.
• Cells from leukemic blood, bone marrow, and solid tumor effusions were analyzed.
• The effects of efflux blockers (phenothiazines, verapamil) on drug retention were assessed.

Main Results:

• Significant heterogeneity in cellular anthracycline retention was observed across different human tumor cells.
• Distinct tumor subpopulations displayed varying sensitivities to efflux modulators.
• Serial samples showed a shift from drug retention and modulator sensitivity to resistance and insensitivity following treatment.

Conclusions:

• Cellular drug retention and sensitivity to efflux modulators are highly variable in human tumors.
• Individual tumor sample screening is essential before employing transport modulators to enhance drug efficacy.
• This personalized approach is necessary to optimize treatment for drug-resistant cancers.